SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (date of earliest event reported): AUGUST 15, 2001
EQUISTAR CHEMICALS, LP
(Exact name of registrant as specified in its charter)
DELAWARE 333-76473 76-0550481
(State or other jurisdiction of (Commission (I.R.S. Employer
incorporation) File Number) Identification No.)
1221 MCKINNEY STREET
SUITE 700, HOUSTON, TEXAS 77010
(Address of principal executive offices and zip code)
Registrant's telephone number, including area code: 713-652-7200
ITEM 9. REGULATION FD DISCLOSURE
As Equistar Chemicals, LP ("Equistar") has previously reported, due to
continued weak conditions in the global chemical markets, management expects
continued poor operating results in the second half of 2001. Pricing and margin
pressures are expected to continue for the remainder of the year in Equistar's
petrochemical and polymers businesses. Published industry data for July
indicate that pricing and margins have deteriorated and, as a result, Equistar's
assessment is that its operating results for the third quarter will be lower
than in the first quarter of 2001.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Equistar Chemicals, LP
By: /s/ Joseph M. Putz
-----------------------------
Joseph M. Putz
Acting Controller
Date: August 15, 2001